Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 2
1948 2
1949 3
1950 6
1951 9
1952 10
1953 6
1954 3
1955 2
1956 4
1957 5
1958 3
1959 5
1960 1
1961 2
1962 2
1963 5
1964 4
1965 4
1966 3
1967 2
1968 2
1969 4
1970 1
1971 4
1974 2
1975 1
1977 1
1978 1
1983 1
1987 2
1988 3
1989 2
1990 3
1991 1
1992 3
1994 1
1995 2
1996 3
1997 1
1998 6
1999 3
2000 4
2002 1
2003 2
2004 8
2005 7
2006 12
2007 11
2008 11
2009 15
2010 16
2011 26
2012 29
2013 25
2014 32
2015 25
2016 35
2017 45
2018 46
2019 36
2020 68
2021 53
2022 59
2023 63
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

690 results

Results by year

Filters applied: . Clear all
Page 1
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, Fischerová D, Jahnn-Kuch D, Joly F, Kohler C, Lax S, Lorusso D, Mahantshetty U, Mathevet P, Naik R, Nout RA, Oaknin A, Peccatori F, Persson J, Querleu D, Bernabé SR, Schmid MP, Stepanyan A, Svintsitskyi V, Tamussino K, Zapardiel I, Lindegaard J. Cibula D, et al. Among authors: joly f. Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429. Int J Gynecol Cancer. 2023. PMID: 37127326 Free PMC article.
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease.
Bischoff SC, Bager P, Escher J, Forbes A, Hébuterne X, Hvas CL, Joly F, Klek S, Krznaric Z, Ockenga J, Schneider S, Shamir R, Stardelova K, Bender DV, Wierdsma N, Weimann A. Bischoff SC, et al. Among authors: joly f. Clin Nutr. 2023 Mar;42(3):352-379. doi: 10.1016/j.clnu.2022.12.004. Epub 2023 Jan 13. Clin Nutr. 2023. PMID: 36739756
ESPEN guideline on home parenteral nutrition.
Pironi L, Boeykens K, Bozzetti F, Joly F, Klek S, Lal S, Lichota M, Mühlebach S, Van Gossum A, Wanten G, Wheatley C, Bischoff SC. Pironi L, et al. Among authors: joly f. Clin Nutr. 2020 Jun;39(6):1645-1666. doi: 10.1016/j.clnu.2020.03.005. Epub 2020 Apr 18. Clin Nutr. 2020. PMID: 32359933 Review.
ESPEN practical guideline: Home parenteral nutrition.
Pironi L, Boeykens K, Bozzetti F, Joly F, Klek S, Lal S, Lichota M, Mühlebach S, Van Gossum A, Wanten G, Wheatley C, Bischoff SC. Pironi L, et al. Among authors: joly f. Clin Nutr. 2023 Mar;42(3):411-430. doi: 10.1016/j.clnu.2022.12.003. Epub 2023 Jan 9. Clin Nutr. 2023. PMID: 36796121
Prevention and treatment of nutritional complications after bariatric surgery.
Nuzzo A, Czernichow S, Hertig A, Ledoux S, Poghosyan T, Quilliot D, Le Gall M, Bado A, Joly F. Nuzzo A, et al. Among authors: joly f. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):238-251. doi: 10.1016/S2468-1253(20)30331-9. Lancet Gastroenterol Hepatol. 2021. PMID: 33581762 Review.
Intestinal adaptation in short bowel syndrome. What is new?
Billiauws L, Thomas M, Le Beyec-Le Bihan J, Joly F. Billiauws L, et al. Among authors: joly f. Nutr Hosp. 2018 May 17;35(3):731-737. doi: 10.20960/nh.1952. Nutr Hosp. 2018. PMID: 29974785 Free article. Review. English.
Medical and surgical management of short bowel syndrome.
Billiauws L, Maggiori L, Joly F, Panis Y. Billiauws L, et al. Among authors: joly f. J Visc Surg. 2018 Sep;155(4):283-291. doi: 10.1016/j.jviscsurg.2017.12.012. Epub 2018 Jul 21. J Visc Surg. 2018. PMID: 30041905 Free article. Review.
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.
Pfister C, Gravis G, Fléchon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulié M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Among authors: joly f. J Clin Oncol. 2022 Jun 20;40(18):2013-2022. doi: 10.1200/JCO.21.02051. Epub 2022 Mar 7. J Clin Oncol. 2022. PMID: 35254888 Clinical Trial.
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C, Gravis G, Fléchon A, Soulié M, Guy L, Laguerre B, Mottet N, Joly F, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Among authors: joly f. Eur Urol. 2021 Feb;79(2):214-221. doi: 10.1016/j.eururo.2020.08.024. Epub 2020 Aug 28. Eur Urol. 2021. PMID: 32868138 Clinical Trial.
690 results